Povidone Iodine Irrıgation at Hip-Knee Arthroplasty
Evaluation of the Systemic Effect of Intraoperative Diluted Povidone Iodine Irrigation Using Urine Iodine and Thyroid Function Tests in Patients Undergoing Knee-Hip Arthroplasty
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Hakan Kocaoglu, MD
- Phone Number: 00903125082321
- Email: kocaoglu@ankara.edu.tr
Study Locations
-
-
-
Ankara, Turkey, 06100
- Recruiting
- Ankara University Faculty of Medicine
-
Contact:
- Hakan Kocaoglu, MD
- Phone Number: 00903125082321
- Email: kocaoglu@ankara.edu.tr
-
Contact:
- Mehmet Batu Ertan, MD
- Phone Number: 00903542190010
- Email: mbatuertan@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All patients with hip/knee osteoarthritis who undergo primary arthroplasty
Exclusion Criteria:
- Patients with abnormal thyroid function tests in the preoperative period, a history of the previous thyroid-related disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Povidone Iodine Solution
The group whom PI solution will be used at surgery
|
3,000 cc of <2% concentrated povidone iodine solution will be used as irrigation solution at primary hip/knee arthroplasty.
The PI solution was left in the joint for 3 minutes.
|
|
Placebo Comparator: Saline Solution
The group whom only saline solution will be used at surgery
|
3,000 cc of 0.9% saline solution will be used as irrigation solution at primary hip/knee arthroplasty.
The saline solution was left in the joint for 3
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urine iodine level
Time Frame: postoperative first day
|
Urine iodine concentration
|
postoperative first day
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thyroid hormone
Time Frame: postoperative 14 days
|
Blood thyroid hormone levels including: TSH, T3 and T4
|
postoperative 14 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Hakan Kocaoglu, MD, Ankara University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Orthop2180
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.